Preferred Label : therapeutic use;

CISMeF acronym : TU;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2842287/fr/trimbow
https://www.has-sante.fr/portail/jcms/c_2842287/fr/trimbow-beclometasone-/-formoterol-/-glycopyrronium-association-corticoide-inhale-csi-bronchodilatateur-beta-2-agoniste-de-longue-duree-d-action-laba-et-bronchodilatateur-anticholinergique-de-longue-duree-d-action-lama
2018
false
false
false
false
France
French
drug combinations
treatment outcome
Formoterol Fumarate
Beclomethasone Dipropionate
Beclomethasone Dipropionate
beclomethasone
glycopyrrolate
administration, inhalation
pulmonary disease, chronic obstructive
adult
glucocorticoids
glucocorticoids
aged
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
muscarinic antagonists
muscarinic antagonists
exacerbation of chronic obstructive bronchitis
formoterol, glycopyrronium bromide and beclometasone
insurance, health, reimbursement
evaluation of the transparency committee
guidelines for drug use
glycopyrrolate
beclomethasone
Formoterol Fumarate

---
https://www.has-sante.fr/portail/jcms/c_2842284/fr/kyntheum
2018
false
false
false
France
French
brodalumab
antibodies, monoclonal
brodalumab
treatment outcome
psoriasis
adult
injections, subcutaneous
Prefilled Syringe Dosage Form
receptors, interleukin-17
receptors, interleukin-17
IL17RA protein, human
insurance, health, reimbursement
evaluation of the transparency committee
brodalumab
antibodies, monoclonal

---
https://www.has-sante.fr/portail/jcms/c_2851016/fr/cosimprel
2018
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
adult
treatment outcome
insurance, health, reimbursement
drug combinations
perindopril
perindopril
Perindopril arginine (substance)
perindopril and bisoprolol
bisoprolol
bisoprolol
angiotensin-converting enzyme inhibitors
angiotensin-converting enzyme inhibitors
adrenergic beta-1 receptor antagonists
adrenergic beta-1 receptor antagonists
bisoprolol fumarate
bisoprolol fumarate
heart failure

---
https://www.has-sante.fr/portail/jcms/c_2857763/fr/votubia
2018
false
false
France
French
Everolimus
adult
spasms, infantile
epilepsies, partial
administration, oral
everolimus
insurance, health, reimbursement
tuberous sclerosis
child
treatment outcome
evaluation of the transparency committee

---
https://www.has-sante.fr/portail/jcms/c_2857802/fr/alecensa
2018
false
false
false
France
French
treatment outcome
administration, oral
carcinoma, non-small-cell lung
alectinib
protein kinase inhibitors
anaplastic lymphoma kinase
adult
aged
antineoplastic agents
evaluation of the transparency committee
survival analysis
ALK gene rearrangement positive
alectinib
CH5424802
carbazoles
piperidines
receptor Protein-Tyrosine kinases

---
Intérêt clinique insuffisant pour justifier son remboursement dans le traitement de la leucémie aiguë myéloïde nouvellement diagnostiquée chez les adultes, quel que soit l’âge, non candidats à une chimiothérapie d’induction standard
https://www.has-sante.fr/portail/jcms/c_2839318/fr/dacogen-decitabine-antimetabolite
https://www.has-sante.fr/portail/jcms/c_2839318/fr/dacogen
2018
false
France
French
insurance, health, reimbursement
guidelines for drug use
decitabine
decitabine
decitabine
infusions, intravenous
adult
aged
leukemia, myeloid, acute
antimetabolites, antineoplastic
antimetabolites, antineoplastic
evaluation of the transparency committee
treatment outcome
clinical trials as topic
survival analysis
orphan drug production
azacitidine

---
Intérêt clinique faible dans les otorrhées sur aérateurs transtympaniques
https://www.has-sante.fr/portail/jcms/c_2839909/fr/ciloxadex-ciprofloxacine-dexamethasone-anti-infectieux-et-corticoide-otorrhees-sur-att
https://www.has-sante.fr/portail/jcms/c_2839909/fr/ciloxadex-otorrhees-sur-att
2018
false
false
France
French
otitis media acute
adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
antibiotic therapy
evaluation of the transparency committee
drug combinations
administration, topical
instillation, drug
insurance, health, reimbursement
ciprofloxacin
Ciprofloxacin Hydrochloride
Ciprofloxacin Hydrochloride
ciprofloxacin
anti-bacterial agents
anti-bacterial agents
dexamethasone
dexamethasone
anti-inflammatory agents
anti-inflammatory agents
treatment outcome
otitis externa
acute disease
otitis media with effusion
middle ear ventilation
glucocorticoids
glucocorticoids
dexamethasone and antiinfectives
otitis media, suppurative
adult
child
clinical trials as topic

---
https://www.has-sante.fr/portail/jcms/c_2843881/fr/duphalac-lactulose-laxatif-osmotique-hypoammoniemiant
https://www.has-sante.fr/portail/jcms/c_2843881/fr/duphalac
2018
false
false
France
French
guidelines for drug use
treatment outcome
Osmotic laxative (substance)
lactulose
administration, oral
lactulose
constipation
hepatic encephalopathy
insurance, health, reimbursement
gastrointestinal agents
evaluation of the transparency committee

---
https://www.has-sante.fr/portail/jcms/c_2844528/fr/auricularum-oxytetracycline-polymyxine-b-dexamethasone-nystatine-anti-infectieux-et-corticoide-en-association
https://www.has-sante.fr/portail/jcms/c_2844528/fr/auricularum-peri-operatoire
2018
false
false
false
false
France
French
evaluation of the transparency committee
instillation, drug
dexamethasone and antiinfectives
auricularum
otitis externa
perioperative period
chronic disease
otitis
ear
perioperative care
treatment outcome
insurance, health, reimbursement
anti-inflammatory agents
glucocorticoids
anti-bacterial agents
antifungal agents
administration, topical
adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
antibiotic therapy
guidelines for drug use
Otomycosis (disorder)
nystatin
oxytetracycline
polymyxin B
dexamethasone
dexamethasone
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2857558/fr/borreliose-de-lyme-et-autres-maladies-vectorielles-a-tiques
2018
false
false
false
France
French
practice guideline
lyme disease
tick-borne diseases
lyme disease
lyme disease
lyme disease
anti-bacterial agents
diagnosis, differential
Drug-Related side effects and adverse reactions

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=670
2018
false
false
false
France
French
technical report
malaria, vivax
france
plasmodium ovale
malaria
Ovale malaria (disorder)
primaquine
primaquine
drug therapy, combination
mass screening
glucosephosphate dehydrogenase deficiency
pregnancy
breast feeding

---
https://www.has-sante.fr/portail/jcms/c_2774117/fr/zydelig-idelalisib-antineoplasique
https://www.has-sante.fr/portail/jcms/c_2774117/fr/zydelig
2018
false
false
false
France
French
treatment outcome
purines
purines
quinazolinones
quinazolinones
antineoplastic agents
antineoplastic agents
administration, oral
leukemia, lymphocytic, chronic, B-Cell
lymphoma, follicular
enzyme inhibitors
enzyme inhibitors
PIK3CB protein, human
antineoplastic combined chemotherapy protocols
adult
idelalisib
idelalisib
idelalisib
evaluation of the transparency committee
guidelines for drug use
Loss of Chromosome 17p
leukemia, lymphocytic, chronic, B-Cell
mutation
genes, p53
Rituximab
continuity of patient care
pneumonia, pneumocystis
neutropenia
phosphatidylinositol 3-Kinases

---
https://www.has-sante.fr/portail/jcms/c_2834705/fr/kisplyx-lenvatinib-inhibiteur-de-tyrosine-kinase
https://www.has-sante.fr/portail/jcms/c_2834705/fr/kisplyx
2018
false
false
false
France
French
lenvatinib
treatment outcome
antineoplastic combined chemotherapy protocols
carcinoma, renal cell
adult
protein kinase inhibitors
protein kinase inhibitors
antineoplastic agents
antineoplastic agents
lenvatinib
administration, oral
protein-tyrosine kinases
receptor Protein-Tyrosine kinases
evaluation of the transparency committee
guidelines for drug use
insurance, health, reimbursement
disease-free survival
Everolimus
lenvatinib
phenylurea compounds
quinolines
phenylurea compounds
quinolines

---
http://www.cochrane.org/fr/CD012197/les-traitements-medicamenteux-pour-le-traitement-de-lapathie-dans-la-maladie-dalzheimer
2018
false
false
false
France
French
french abstract
alzheimer disease
apathy
review of literature
modafinil
methylphenidate
Evidence-Based medicine
central nervous system stimulants
methylphenidate
modafinil
placebos
randomized controlled trials as topic
benzhydryl compounds

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Keytruda-pembrolizumab-Restriction-d-indication-dans-le-traitement-des-patients-adultes-atteints-d-un-carcinome-urothelial-localement-avance-ou-metastatique-ineligibles-a-une-chimiotherapie-a-base-de-cisplatine-Lettre-aux-professionnels-de-sante
2018
false
false
false
France
French
guidelines for drug use
pembrolizumab
pembrolizumab
neoplasm metastasis
Locally Advanced Malignant Neoplasm
Urothelial Carcinoma
survival analysis
infusions, intravenous
antineoplastic agents
urologic neoplasms
antibodies, monoclonal
antibodies, monoclonal, humanized

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Tecentriq-R-atezolizumab-Restriction-d-indication-dans-le-traitement-des-patients-adultes-atteints-d-un-carcinome-urothelial-localement-avance-ou-metastatique-ineligibles-a-une-chimiotherapie-a-base-de-cisplatine-Lettre-aux-professionnels-de-sante
2018
false
false
false
France
French
guidelines for drug use
atezolizumab
monoclonal antibodies
infusions, intravenous
antineoplastic agents
adult
neoplasm metastasis
Locally Advanced Malignant Neoplasm
Urothelial Carcinoma
urologic neoplasms
survival analysis
antibodies, monoclonal

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/L-ANSM-rappelle-la-necessite-de-disposer-d-une-nouvelle-prescription-pour-obtenir-Exjade-90-mg-ou-360-mg-comprimes-pellicules-seule-forme-disponible-a-compter-du-26-juillet-2018-Point-d-information
2018
false
false
false
France
French
drug prescriptions
administration, oral
deferasirox
guidelines for drug use
patient education handout
iron overload
iron chelating agents
iron chelating agents
beta-Thalassemia
blood transfusion
medication errors
deferasirox
deferasirox
triazoles
benzoates
triazoles
benzoates

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004449/human_med_002263.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Heterocyclic Compounds, 4 or More Rings
Heterocyclic Compounds, 4 or More Rings
Emtricitabine
drug combinations
tenofovir alafenamide
tenofovir alafenamide
drug approval
europe
emtricitabine, tenofovir alafenamide and bictegravir
hiv infections
adult
drug interactions
pregnancy
breast feeding
administration, oral
HIV integrase inhibitors
HIV integrase inhibitors
anti-hiv agents
anti-hiv agents
reverse transcriptase inhibitors
reverse transcriptase inhibitors
product surveillance, postmarketing
aged
drug evaluation, preclinical
treatment outcome
Tenofovir
Emtricitabine
adenine
GS-7340
GS-7340

---
Verkazia ciclosporin
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004411/human_med_002167.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
orphan drug production
child
adolescent
Vernal keratoconjunctivitis
keratoconjunctivitis, vernal
cyclosporine
cyclosporine
administration, ophthalmic
ophthalmic solutions
ciclosporin
keratoconjunctivitis, vernal
immunosuppressive agents
immunosuppressive agents
drug interactions
pregnancy
breast feeding
fertility
Calcineurin Inhibitors
Calcineurin Inhibitors
drug evaluation, preclinical
conjunctivitis, allergic
conjunctivitis, allergic

---
http://ansm.sante.fr/S-informer/Actualite/Arret-de-fabrication-de-la-Benzathine-benzylpenicilline-du-laboratoire-Sandoz-Securisation-de-l-approvisionnement-en-Extencilline-Point-d-information
2018
false
false
false
France
French
pharmacovigilance note
drug recalls
penicillin G benzathine
anti-bacterial agents
anti-bacterial agents
penicillin G benzathine
syphilis
injections, intramuscular
rheumatic fever
recurrence
antibiotic prophylaxis
Recurrent erysipelas (disorder)
erysipelas
benzathine benzylpenicillin

---
http://www.reseau-naissance.fr/medias/2018/07/Referentiel_anticoag_accouchement_RSN_2018VF-1.pdf
2018
false
false
false
France
French
anticoagulants
anticoagulants
guidelines for drug use
pregnancy
heparin
heparin
thromboembolism
heart valve prosthesis
continuity of patient care
vitamin K
antivitamins K
parturition
injections, subcutaneous
injections, intravenous
administration, oral
anesthesia, epidural
indenes
4-hydroxycoumarins

---
https://www.has-sante.fr/portail/jcms/c_2847939/fr/vemlidy
2018
false
false
false
France
French
antiviral agents
treatment outcome
tenofovir alafenamide
adult
adolescent
hepatitis B, chronic
administration, oral
reverse transcriptase inhibitors
aged
evaluation of the transparency committee
insurance, health, reimbursement
tenofovir alafenamide
GS-7340
adenine

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002321/human_med_001499.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500109010
2018
false
United Kingdom
English
French
summary of product characteristics
package leaflet
drug evaluation
syndication feed
Abiraterone Acetate
Abiraterone Acetate
drug interactions
steroid 17-alpha-hydroxylase
clinical trials, phase iii as topic
survival analysis
drug evaluation, preclinical
treatment outcome
drug approval
administration, oral
abiraterone
prostatic neoplasms
adult
neoplasm metastasis
drug therapy, combination

---
http://www.cochrane.org/fr/CD004879/les-vaccins-pour-la-prevention-de-la-grippe-chez-les-enfants-en-bonne-sante
2018
false
false
France
French
meta-analysis
influenza vaccines
influenza, human
child
treatment outcome
infant
french abstract

---
http://www.cps.ca/fr/documents/position/reduire-les-risques-infection-apres-transplantation-organe-pediatrie
2018
false
false
Canada
French
organ transplantation
child
infection control
practice guideline
vaccines
vaccination
serologic tests
immunosuppressive agents
infant

---
http://www.cochrane.org/fr/CD001269/les-vaccins-pour-la-prevention-de-la-grippe-chez-les-adultes-en-bonne-sante
2018
false
false
France
French
meta-analysis
influenza vaccines
influenza, human
treatment outcome
adult
french abstract

---
http://www.cochrane.org/fr/CD008980/les-inhibiteurs-du-facteur-xa-compares-aux-antagonistes-de-la-vitamine-k-pour-la-prevention-de
2018
false
false
France
French
review of literature
french abstract
thromboembolism
vitamin K
atrial fibrillation
antithrombin III
antifibrinolytic agents
treatment outcome

---
https://www.anses.fr/fr/content/l%E2%80%99anses-recommande-%C3%A0-certaines-populations-d%E2%80%99%C3%A9viter-la-consommation-de-compl%C3%A9ments
2018
false
false
false
France
French
melatonin
melatonin
dietary supplements
dietary supplements
public health guidelines
sleep initiation and maintenance disorders
child
adult
legislation, drug
drug overdose
serotonin syndrome
arrhythmias, cardiac
tremor
digestive system diseases
nausea
headache
psychomotor agitation
spasm
fatigue
abdominal pain
depressive disorder
pregnancy
breast feeding
epilepsy
melatonin

---
https://www.has-sante.fr/portail/jcms/c_2831687/fr/qutenza
https://www.has-sante.fr/portail/jcms/c_2831687/fr/qutenza-capsaicine-antalgique-local-en-patch
2018
false
false
France
French
insurance, health, reimbursement
sensory system agents
sensory system agents
guidelines for drug use
transdermal patch
diabetic neuropathies
trpv cation channels
TRPV1 protein, human
capsaicin
administration, cutaneous
adult
capsaicin
capsaicin
treatment outcome
evaluation of the transparency committee

---
http://www.cfp.ca/content/64/4/296
2018
false
false
false
Canada
French
diabetes mellitus, type 2
cardiovascular diseases
treatment outcome
Evidence-Based medicine
hypoglycemic agents
sulfonylurea compounds
cardiovascular diseases
Sulfonylurea Antidiabetic Agent
journal article

---
https://www.sfdiabete.org/sites/www.sfdiabete.org/files/files/ressources/reco_sfd_surveillance_glycemique_mars2017.pdf
2018
false
false
false
France
French
blood glucose self-monitoring
glucagon-like peptide 1
practice guideline
patient education as topic
Glucagon-like peptide-1 (GLP-1) analogues
injections, subcutaneous
GLP-1 Mimetics
Capillary blood glucose measurement (procedure)
Capillary specimen collection (procedure)
acetone
acetone
diabetes mellitus
continuity of patient care
ketosis
ketosis
diabetes mellitus
blood glucose
quality control
insulin
Insulin lipohypertrophy (disorder)
Subcutaneous injection of insulin (procedure)
Subcutaneous injection of insulin (procedure)
Insulin administration assessment (procedure)
questionnaires
Initiation of first time insulin therapy (regime/therapy)

---
https://www.rmlg.ulg.ac.be/aboel.php?num_id=2996&langue=FR
2018
false
false
false
Belgium
French
child
otitis media
journal article
acute disease
otitis media
otitis media
anti-bacterial agents
amoxicillin

---
https://www.has-sante.fr/portail/jcms/c_2847925/fr/entocort
2018
false
false
false
false
France
French
evaluation of the transparency committee
colitis, microscopic
remission induction
treatment outcome
insurance, health, reimbursement
administration, oral
budesonide
budesonide
budesonide
anti-inflammatory agents
anti-inflammatory agents
glucocorticoids
glucocorticoids

---
http://www.cfp.ca/content/64/5/e209?etoc
2018
false
false
false
Canada
French
receptors, GABA-A
Deprescriptions
practice guideline
sleep initiation and maintenance disorders
aged
adult
algorithms

---
https://www.has-sante.fr/portail/jcms/c_2848372/fr/celsentri
2018
false
false
false
false
France
French
evaluation of the transparency committee
maraviroc
adolescent
child
adult
treatment outcome
guidelines for drug use
HIV-1
hiv infections
hiv infections
CCR5 Receptor Antagonists
CCR5 Receptor Antagonists
genotype drug resistance test
maraviroc
selzentry
maraviroc
cyclohexanes
triazoles
cyclohexanes
triazoles
cyclohexanes
triazoles

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Utilisation-des-immunoglobulines-humaines-polyvalentes-Ig-dans-un-contexte-de-fortes-tensions-d-approvisionnement-diffusion-d-une-note-d-information-relative-a-la-hierarchisation-des-indications-Point-d-Information
2018
false
false
false
France
French
guidelines for drug use
immunoglobulins
immunologic factors
immunologic factors
immunoglobulins, normal human
Human immunoglobulin (substance)
immunologic deficiency syndromes
Primary immune deficiency disorder (disorder)
autoimmune diseases of the nervous system
rh isoimmunization
red-cell aplasia, pure
purpura, thrombocytopenic, idiopathic
von willebrand diseases
gammopathy, monoclonal
Post-Exposure prophylaxis
immunocompromised host
pregnancy
child
adult
organ transplantation
graft rejection
graft rejection
mucocutaneous lymph node syndrome
drug prescriptions
paraproteinemias

---
ansm.sante.fr/S-informer/Points-d-information-Points-d-information/L-ANSM-rappelle-le-cadre-reglementaire-concernant-la-realisation-de-preparations-a-base-de-melatonine-Point-d-Information
2018
false
false
false
France
French
guideline
melatonin
legislation, drug
melatonin
administration, oral
drug approval
drug interactions
melatonin
legislation, pharmacy
Off-Label use
melatonin
adult
child
central nervous system depressants
central nervous system depressants
central nervous system depressants

---
https://www.revmed.ch/RMS/2017/RMS-N-565/Association-des-analogues-du-GLP-1-et-des-inhibiteurs-du-SGLT2-de-nouvelles-perspectives
2018
false
false
false
Switzerland
French
journal article
administration, oral
hypoglycemic agents
diabetes mellitus, type 2
switzerland
treatment outcome
body weight
cardiovascular diseases
drug therapy, combination
GLP-1 Mimetics
glucagon-like peptide 1
Glucagon-like peptide-1 (GLP-1) analogues
SGLT2 Inhibitor
Sodium-Glucose transporter 2
exenatide
dulaglutide
Liraglutide
empagliflozin
dapagliflozin
Canagliflozin
blood glucose
arterial pressure
genetic pleiotropy
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
peptides
venoms
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
glucagon-like peptides
benzhydryl compounds
glucosides

---
http://www.omedit-centre.fr/portail/gallery_files/site/136/2953/5062/8120.pdf
2018
false
false
false
false
France
French
aged
pain
pain
guidelines for drug use
analgesics, opioid
analgesics, non-narcotic
pain management
administration, oral
administration, cutaneous

---
http://www.omedit-centre.fr/portail/gallery_files/site/136/2953/5062/8128.pdf
2018
false
false
false
France
French
guidelines for drug use
aged
urinary tract infections
anti-infective agents, urinary
urinary tract infections
anti-bacterial agents
acute disease
Infection due to antimicrobial resistant bacteria (disorder)
drug resistance, bacterial
urinary catheters
urinary catheterization
continuity of patient care
urinary tract infections

---
http://www.omedit-centre.fr/portail/gallery_files/site/136/2953/5062/8129.pdf
2018
false
false
false
France
French
prostatitis
acute disease
guidelines for drug use
prostatitis
Infection due to extended spectrum beta-lactamase producing bacteria (disorder)
risk factors
drug resistance, bacterial
hospitalization
anti-bacterial agents
fluoroquinolones
fluoroquinolones

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Recommandations-d-utilisation-des-inhibiteurs-de-la-C1-esterase-humaine-Cinryze-et-Berinert-en-periode-de-tensions-d-approvisionnement-Point-d-Information
2018
false
false
false
France
French
pharmacovigilance note
guidelines for drug use
SERPING1 protein, human
SERPING1 protein, human
injections, intravenous
infusions, intravenous
angioedemas, hereditary
angioedemas, hereditary
pregnancy
child
C1-inhibitor, plasma derived
SERPING1 protein, human
injections, subcutaneous
algorithms
icatibant
conestat alpha
recombinant proteins
conestat alfa
complement C1 inhibitor protein
complement C1 inhibitor protein
complement C1 inhibitor protein
icatibant
danazol
dexchlorpheniramine
histamine h1 antagonists
epinephrine
adult
complement c1 inactivator proteins
complement c1 inactivator proteins
complement c1 inactivator proteins
bradykinin
bradykinin
chlorpheniramine

---
https://www.has-sante.fr/portail/jcms/c_2851086/fr/les-anticoagulants-oraux
2018
false
false
false
France
French
guidelines for drug use
anticoagulants
anticoagulants
administration, oral
antivitamins K
antivitamins K
atrial fibrillation
drug overdose
apixaban
Dabigatran
antithrombins
Factor Xa Inhibitors
Rivaroxaban
edoxaban
Direct factor Xa inhibitors
direct thrombin inhibitors
pregnancy
patient compliance
continuity of patient care
hemorrhage
surgical procedures, operative
blood loss, surgical
hemorrhage
vitamin k antagonists
fluindione
acenocoumarol
warfarin
pyridines
thiazoles
phenindione
phenindione
indenes
4-hydroxycoumarins
vitamin K
vitamin K
indenes
4-hydroxycoumarins
vitamin K
pyrazoles
pyridones

---
https://www.rheuma-net.ch/fr/dok/sgr-dokumente/behandlung/therapie-fr/biologics-fr/366-anti-tnf/file?force-download=1
2018
false
false
false
Switzerland
French
guidelines for drug use
CT-P13
tumor necrosis factor alpha (tnf-alpha) inhibitors
infusions, intravenous
antibodies, monoclonal
tumor necrosis factor-alpha
Infliximab
biosimilar pharmaceuticals
golimumab
antirheumatic agents
-
Etanercept
injections, subcutaneous
Certolizumab Pegol
Adalimumab
arthritis, rheumatoid
arthritis, psoriatic
Axial spondyloarthritis (disorder)
Juvenile Idiopathic Arthritis
arthritis, juvenile
continuity of patient care

---
https://www.rheuma-net.ch/fr/dok/sgr-dokumente/behandlung/therapie-fr/biologics-fr/371-ustekinumab-1/file?force-download=1
2018
false
false
false
Switzerland
French
guidelines for drug use
Ustekinumab
arthritis, psoriatic
infusions, intravenous
injections, subcutaneous
continuity of patient care
ustekinumab
antirheumatic agents
interleukin-12 subunit p40

---
https://www.rheuma-net.ch/fr/dok/sgr-dokumente/behandlung/therapie-fr/biologics-fr/370-tocilizumab-1/file?force-download=1
2018
false
false
false
Switzerland
French
guidelines for drug use
tocilizumab
tocilizumab
arthritis, rheumatoid
Laboratory Procedure
continuity of patient care
clinical chemistry tests
IL6R protein, human
infusions, intravenous
injections, subcutaneous
antibodies, monoclonal, humanized
receptors, interleukin-6

---
https://www.rheuma-net.ch/fr/dok/sgr-dokumente/behandlung/therapie-fr/biologics-fr/369-secukinumab-1/file?force-download=1
2018
false
false
false
Switzerland
French
guidelines for drug use
secukinumab
continuity of patient care
secukinumab
injections, subcutaneous
adult
arthritis, psoriatic
spondylitis, ankylosing
Interleukin-17A
psoriasis
Interleukin-17
antibodies, monoclonal

---
https://www.rheuma-net.ch/fr/dok/sgr-dokumente/behandlung/therapie-fr/targeted-synthetic-dmards/364-inhibiteurs-des-janus-kinases-jakinhibs/file?force-download=1
2018
false
false
false
Switzerland
French
continuity of patient care
Janus kinase inhibitor (substance)
guidelines for drug use
tofacitinib
tofacitinib
drug interactions
arthritis, rheumatoid
janus kinases
protein kinase inhibitors
baricitinib
baricitinib
antirheumatic agents
administration, oral
Tuberculosis screening (procedure)
Precaution
pyrimidines
pyrroles
piperidines
azetidines
sulfonamides

---
https://www.rheuma-net.ch/fr/dok/sgr-dokumente/behandlung/therapie-fr/targeted-synthetic-dmards/363-apremilast-1/file?force-download=1
2018
false
false
false
Switzerland
French
guidelines for drug use
continuity of patient care
apremilast
apremilast
phosphodiesterase 4 inhibitors
administration, oral
arthritis, psoriatic
adult
Precaution
thalidomide
thalidomide

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Baclofene-dans-l-alcoolo-dependance-Publication-de-l-avis-du-CSST-sur-le-rapport-benefice-risque-Point-d-information
2018
false
false
false
France
French
drug information
baclofen
alcoholism
risk assessment
drug approval

---
https://www.revmed.ch/RMS/2017/RMS-N-559/Denosumab-en-routine-clinique-precautions-a-prendre-avant-pendant-et-apres
2018
false
false
false
Switzerland
French
journal article
continuity of patient care
treatment outcome
Denosumab
denosumab
injections, subcutaneous
Denosumab
osteoporosis
rank ligand
renal insufficiency
calcium
osteoporosis, postmenopausal
Calcium supplement therapy (regime/therapy)
calcium
Vitamin D supplement therapy (regime/therapy)
case reports
spinal fractures
therapy cessation
hypocalcemia
vitamin d deficiency
bone density conservation agents
bone density conservation agents
rebound effect
diphosphonates
fractures, spontaneous
bone neoplasms
bone neoplasms

---
http://www.omedit-aquitaine.fr/sites/omedit.drupal7.aquisante.priv/files/54/livret_constipation.pdf
2018
false
false
false
France
French
constipation
constipation
practice guideline
constipation
constipation
constipation
laxatives
mental disorders
constipation
Healthy Lifestyle
intestinal obstruction
guidelines for drug use
algorithms
drug interactions
Anthraquinone laxative (substance)
paraffin oils
adult
child
administration, oral
administration, rectal
drugs for constipation
bulk laxatives
polyethylene glycols
Stool softener (substance)
Osmotic laxative (substance)
enema
oils
paraffin

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=650
2018
false
false
false
France
French
mayotte
malaria, falciparum
primaquine
primaquine
practice guideline
practice guidelines as topic
primaquine
continuity of patient care
world health organization
comoros

---
http://www.prescrire.org/Fr/3/31/55116/0/NewsDetails.aspx
2018
false
false
false
false
France
French
alzheimer disease
treatment outcome
donepezil hydrochloride
donepezil
cholinesterase inhibitors
cholinesterase inhibitors
insurance, health, reimbursement
alzheimer disease
memantine
memantine
memantine hydrochloride
receptors, n-methyl-d-aspartate
excitatory amino acid antagonists
excitatory amino acid antagonists
administration, oral
administration, cutaneous
Rivastigmine
rivastigmine
galantamine
Galanthamine Hydrobromide
quality of life
france
journal article
galantamine
donepezil
indans
piperidines

---
www.sfendocrino.org/article/951/modification-de-presentation-insuline-fiasp-reg
2018
false
false
false
France
French
pharmacovigilance note
insulin aspart
administration, oral
medication errors

---
Kan liraglutide de kans op type 2-diabetes verminderen bij patiënten met prediabetes?
http://www.minerva-ebm.be/FR/Article/2164
2018
false
false
false
Belgium
French
Dutch
treatment outcome
diabetes mellitus, type 2
prediabetic state
Liraglutide
hypoglycemic agents
incretins
critical appraisal or critical reading
risk factors
cardiovascular diseases
placebos
obesity
Glucagon-Like Peptide-1 Receptor
blood glucose
weight loss

---
Smectite for acute infectious diarrhoea in children
http://www.cochrane.org/fr/CD011526/la-smectite-pour-la-diarrhee-infectieuse-aigue-chez-les-enfants
2018
false
false
false
France
French
English
french abstract
child
diarrhea
acute disease
Acute diarrhea (disorder)
treatment outcome
review of literature
Smectite
Evidence-Based medicine
dysentery
silicates

---
Antidepressants for panic disorder in adults
http://www.cochrane.org/fr/CD010676/les-antidepresseurs-par-rapport-un-placebo-pour-le-traitement-du-trouble-panique-chez-ladulte
2018
false
false
false
France
French
English
french abstract
review of literature
antidepressive agents
adult
Evidence-Based medicine
panic disorder
placebos
treatment outcome

---
Ivermectin and permethrin for treating scabies
http://www.cochrane.org/fr/CD012994/livermectine-et-la-permethrine-pour-le-traitement-de-la-gale
2018
false
false
false
France
French
french abstract
review of literature
Evidence-Based medicine
treatment outcome
ivermectin
ivermectin
scabies
antiparasitic agents
permethrin
administration, cutaneous
permethrin
permethrin
ivermectin
administration, oral

---
Alpivab peramivir
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004299/human_med_002243.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
peramivir
drug approval
europe
treatment outcome
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
neuraminidase
antiviral agents
antiviral agents
enzyme inhibitors
enzyme inhibitors
neuraminidase inhibitors
product surveillance, postmarketing
drug monitoring
influenza, human
adult
child
adolescent
infusions, intravenous
peramivir
cyclopentanes
guanidines
cyclopentanes
guanidines
cyclopentanes
guanidines

---
Steglatro - ertugliflozin
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004315/human_med_002241.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
ertugliflozin
administration, oral
diabetes mellitus, type 2
drug approval
europe
treatment outcome
hypoglycemic agents
hypoglycemic agents
product surveillance, postmarketing
drug monitoring
adult
Sodium-glucose co-transporter 2 (SGLT2) inhibitors
SGLT2 Inhibitor
SGLT2 Inhibitor
Sodium-Glucose transporter 2
drug interactions
pregnancy
breast feeding
drug therapy, combination
ertugliflozin
5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol
bicyclo compounds, heterocyclic
5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol
5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol
bicyclo compounds, heterocyclic
bicyclo compounds, heterocyclic

---
Lokelma sodium zirconium cyclosilicate
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004029/human_med_002084.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
sodium zirconium cyclosilicate
treatment outcome
drug approval
europe
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
sodium zirconium cyclosilicate
sodium zirconium cyclosilicate
hyperkalemia
administration, oral
adult
ZS-9 compound
ZS-9 compound
silicates
silicates

---
Segluromet ertugliflozin / metformin hydrochloride
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004314/human_med_002238.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
SGLT2 Inhibitor
SGLT2 Inhibitor
metformin
hypoglycemic agents
hypoglycemic agents
drug combinations
administration, oral
europe
drug approval
treatment outcome
ertugliflozin
product surveillance, postmarketing
drug monitoring
combinations of oral blood glucose lowering drugs
diabetes mellitus, type 2
drug interactions
pregnancy
breast feeding
adult
Metformin Hydrochloride
Metformin Hydrochloride
drug evaluation, preclinical
Sodium-Glucose transporter 2
ertugliflozin
metformin
5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol
bicyclo compounds, heterocyclic
5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol
5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol
bicyclo compounds, heterocyclic
bicyclo compounds, heterocyclic

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004258/human_med_002222.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
drug monitoring
immunosuppressants
immunosuppressive agents
immunosuppressive agents
orphan drug production
crohn disease
anal fistula
cell therapy
Somatic Cell
injections
rectal fistula
cell- and Tissue-Based therapy

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004272/human_med_002215.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
rucaparib
drug approval
europe
treatment outcome
rucaparib
orphan drug production
ovarian neoplasms
fallopian tube neoplasms
peritoneal neoplasms
adult
mutation
fallopian tube neoplasms
ovarian neoplasms
peritoneal neoplasms
administration, oral
tablets
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerase Inhibitors
product surveillance, postmarketing
drug monitoring
drug interactions
pregnancy
breast feeding
genes, BRCA1
genes, BRCA2
drug evaluation, preclinical
rucaparib
indoles
indoles
indoles

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004427/human_med_002254.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Rilpivirine
dolutegravir
drug combinations
dolutegravir and rilpivirine
drug approval
europe
treatment outcome
HIV integrase inhibitors
HIV integrase inhibitors
reverse transcriptase inhibitors
reverse transcriptase inhibitors
hiv infections
HIV-1
adult
administration, oral
product surveillance, postmarketing
drug monitoring
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
dolutegravir
Rilpivirine
heterocyclic compounds, 3-ring
heterocyclic compounds, 3-ring
heterocyclic compounds, 3-ring

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004204/human_med_002252.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
gemtuzumab ozogamicin
drug approval
europe
treatment outcome
orphan drug production
product surveillance, postmarketing
drug monitoring
gemtuzumab ozogamicin
adolescent
adult
antineoplastic agents
antineoplastic agents
leukemia, myeloid, acute
antineoplastic combined chemotherapy protocols
leukemia, promyelocytic, acute
CD33 protein, human
infusions, intravenous
drug interactions
immunotoxins
immunotoxins
pregnancy
breast feeding
Female of child bearing age (finding)
drug evaluation, preclinical
gemtuzumab
gemtuzumab ozogamicin
aminoglycosides
antibodies, monoclonal, humanized
gemtuzumab
gemtuzumab
aminoglycosides
antibodies, monoclonal, humanized
aminoglycosides
antibodies, monoclonal, humanized
sialic acid binding ig-like lectin 3

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004379/human_med_002228.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
glyburide
drug approval
europe
orphan drug production
child
treatment outcome
administration, oral
Oral Suspension Dosage Form
hypoglycemic agents
hypoglycemic agents
diabetes mellitus
glibenclamide
infant, newborn
infant
Neonatal diabetes mellitus
diabetes mellitus
mutation
drug interactions
katp channels
insulin-secreting cells
6q24-Related transient neonatal diabetes mellitus
drug evaluation, preclinical
glyburide

---
https://www.revmed.ch/RMS/2017/RMS-N-566/Outil-d-aide-a-la-decision-comparant-les-traitements-pharmacologiques-pour-l-arret-du-tabac
https://www.pmu-lausanne.ch/sites/default/files/inline-files/pmu-tableau-arret-tabac.pdf
2018
false
false
false
Switzerland
French
journal article
tobacco use cessation products
smoking cessation
smoking
decision support techniques
patient preference
nicotine replacement products
nicotinic agonists
Varenicline
drugs used in nicotine dependence
bupropion
treatment outcome
administration, oral
administration, buccal
administration, intranasal
administration, cutaneous

---
http://www.omedit-centre.fr/portail/gallery_files/site/136/2953/5062/8124.pdf
2018
false
false
false
France
French
guidelines for drug use
administration, inhalation
meopa
acute pain
acute pain
patient care
ambulatory care
home care services, hospital-based
pressure ulcer
drug storage
skin ulcer
nitrous oxide
oxygen compounds

---
http://www.omedit-centre.fr/portail/gallery_files/site/136/2953/5062/8134.pdf
2018
false
false
false
France
French
herpes zoster
herpes zoster
antiviral agents
vaccination
herpes zoster vaccine
guidelines for drug use
acyclovir
valacyclovir
immunocompromised host
infectious disease transmission, Patient-to-Professional
child
adult
adolescent
acyclovir
valine
valine

---
http://www.omedit-centre.fr/portail/gallery_files/site/136/2953/5062/8133.pdf
2018
false
false
false
France
French
guidelines for drug use
chickenpox
chickenpox
antiviral agents
pregnancy
immunocompromised host
infant, newborn
child
adolescent
adult
acyclovir
injections, intravenous
chickenpox vaccine
vaccination
administration, oral
valacyclovir
infectious disease transmission, vertical
acyclovir
valine
valine

---
https://www.has-sante.fr/portail/jcms/c_2838905/fr/place-du-vaccin-synflorix-dans-la-strategie-vaccinale-contre-les-infections-a-pneumocoques-chez-l-enfant-age-de-moins-de-5-ans
2018
false
France
French
otitis media acute
pneumococcal vaccines
pneumococcal vaccines
vaccines, conjugate
vaccination
infant
pneumococcal infections
treatment outcome
immunization schedule
immunization, secondary
otitis media
acute disease
injections, intramuscular
polysaccharides, bacterial
polysaccharides, bacterial
streptococcus pneumoniae
polysaccharides, bacterial
guidelines for drug use
france
pneumonia, bacterial
pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated

---
http://www.rifhop.net/sites/rifhop.net/files/TRA_04.pdf
2018
false
false
false
France
French
Packed red blood cells (product)
erythrocytes
child
infant
continuity of patient care
Packed Red Blood Cell Transfusion
Pediatric Oncology

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003958/human_med_002256.jsp&mid=WC0b01ac058001d124
2018
false
United Kingdom
English
French
syndication feed
drugs, generic
Pemetrexed
Pemetrexed
Pemetrexed (product)
Pleural Malignant Mesothelioma
antineoplastic combined chemotherapy protocols
antimetabolites, antineoplastic
antineoplastic agents
folic acid antagonists
mesothelioma
carcinoma, non-small-cell lung
thymidylate synthase
treatment outcome
drug approval
infusions, intravenous
pleural neoplasms
continuity of patient care
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pemetrexed
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004644/human_med_002249.jsp&mid=WC0b01ac058001d124
2018
false
United Kingdom
French
English
syndication feed
Prasugrel Hydrochloride
Prasugrel Hydrochloride
drugs, generic
drug therapy, combination
aspirin
acute coronary syndrome
angioplasty, balloon, coronary
platelet aggregation inhibitors
platelet aggregation inhibitors
adult
drug interactions
pregnancy
breast feeding
tablets
administration, oral
membrane proteins
treatment outcome
drug evaluation, preclinical
thrombosis
atherosclerosis
prasugrel
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
summary of product characteristics
drug evaluation
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004361/human_med_002255.jsp&mid=WC0b01ac058001d124
2018
false
United Kingdom
French
English
syndication feed
Trastuzumab
Trastuzumab
biosimilar pharmaceuticals
europe
drug interactions
stomach neoplasms
product surveillance, postmarketing
antineoplastic combined chemotherapy protocols
Gastroesophageal Junction Adenocarcinoma
Gastric Adenocarcinoma
HER-2 positive breast cancer
HER-2 positive gastric cancer
Trastuzumab 150mg powder for infusion solution vial (product)
antineoplastic agents
antineoplastic agents
treatment outcome
drug evaluation
infusions, intravenous
drug approval
receptor, erbB-2
neoplasm metastasis
pregnancy
breast feeding
drug storage
drug compounding
breast neoplasms
trastuzumab
antibodies, monoclonal
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004280/human_med_002239.jsp&mid=WC0b01ac058001d124
2018
false
United Kingdom
French
English
syndication feed
Insulin Glargine
Insulin Glargine
biosimilar pharmaceuticals
drug approval
europe
Insulin glargine 100units/mL injection solution 3mL cartridge (product)
Insulin glargine 100units/mL injection solution 3mL prefilled disposable injection device (product)
child, preschool
diabetes mellitus
adult
child
adolescent
hypoglycemic agents
hypoglycemic agents
treatment outcome
drug evaluation
injections, subcutaneous
insulin glargine
drug evaluation
summary of product characteristics
package leaflet

---
Trydonis - beclometasone / formoterol / glycopyrronium bromide
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004702/human_med_002250.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
drug combinations
treatment outcome
Formoterol Fumarate
Beclomethasone Dipropionate
Beclomethasone Dipropionate
beclomethasone
glycopyrrolate
administration, inhalation
pulmonary disease, chronic obstructive
adult
glucocorticoids
glucocorticoids
aged
drug interactions
pregnancy
breast feeding
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
muscarinic antagonists
muscarinic antagonists
exacerbation of chronic obstructive bronchitis
forced expiratory volume
drug evaluation, preclinical
formoterol, glycopyrronium bromide and beclometasone
drug evaluation
glycopyrrolate
beclomethasone
Formoterol Fumarate

---
Riarify (previously CHF 5993 Chiesi Farmaceutici S.p.A.) - beclometasone / formoterol / glycopyrronium bromide
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004836/human_med_002246.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
drug combinations
treatment outcome
Formoterol Fumarate
Beclomethasone Dipropionate
Beclomethasone Dipropionate
beclomethasone
glycopyrrolate
administration, inhalation
pulmonary disease, chronic obstructive
adult
glucocorticoids
glucocorticoids
aged
drug interactions
pregnancy
breast feeding
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
anti-inflammatory agents
muscarinic antagonists
muscarinic antagonists
exacerbation of chronic obstructive bronchitis
forced expiratory volume
drug evaluation, preclinical
formoterol, glycopyrronium bromide and beclometasone
drug evaluation
glycopyrrolate
beclomethasone
Formoterol Fumarate

---
Steglujan - ertugliflozin / sitagliptin
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004313/human_med_002242.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
SGLT2 Inhibitor
SGLT2 Inhibitor
hypoglycemic agents
hypoglycemic agents
drug combinations
administration, oral
europe
drug approval
treatment outcome
ertugliflozin
product surveillance, postmarketing
drug monitoring
combinations of oral blood glucose lowering drugs
diabetes mellitus, type 2
drug interactions
pregnancy
breast feeding
adult
drug evaluation, preclinical
Sodium-Glucose transporter 2
Sitagliptin Phosphate
Sitagliptin Phosphate
incretins
incretins
dipeptidyl-peptidase iv inhibitors
dipeptidyl-peptidase iv inhibitors
ertugliflozin
5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol
bicyclo compounds, heterocyclic
5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol
5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol
bicyclo compounds, heterocyclic
bicyclo compounds, heterocyclic

---
Mise à disposition d'un médicament hybride de LEVACT.
https://www.has-sante.fr/portail/jcms/c_2821744/fr/bendamustine-reddy
2018
false
false
France
French
English
Bendamustine Hydrochloride
Parenteral form bendamustine (product)
bendamustine
antineoplastic agents
leukemia, lymphocytic, chronic, B-Cell
lymphoma, Non-Hodgkin
multiple myeloma
infusions, parenteral
treatment outcome
evaluation of the transparency committee

---
https://www.has-sante.fr/portail/jcms/c_2827573/fr/kisqali
https://www.has-sante.fr/portail/jcms/c_2827573/fr/kisqali-ribociclib-inhibiteur-de-proteine-kinase-cdk-4/6
2018
false
false
false
France
French
treatment outcome
ribociclib
ribociclib
neoplasm metastasis
Locally Advanced Malignant Neoplasm
antineoplastic agents
antineoplastic agents
Locally advanced breast cancer
breast neoplasms
postmenopause
Stage IV Breast Cancer AJCC v6 and v7
Hormone receptor positive malignant neoplasm of breast (disorder)
administration, oral
HER2/Neu Negative
Cyclin-Dependent kinase 4
Cyclin-Dependent kinase 6
protein kinase inhibitors
protein kinase inhibitors
antineoplastic combined chemotherapy protocols
adult
aged
ribociclib
evaluation of the transparency committee
guidelines for drug use
aminopyridines
purines
aminopyridines
purines

---
https://www.has-sante.fr/portail/jcms/c_2826827/fr/lixiana
2018
false
false
false
France
French
English
treatment outcome
edoxaban
Edoxaban Tosylate
administration, oral
stroke
embolism
adult
risk factors
atrial fibrillation
deep vein thrombosis
deep vein thrombosis
recurrence
pulmonary embolism
pulmonary embolism
hemorrhage
edoxaban
hemorrhage
Factor Xa Inhibitors
edoxaban
evaluation of the transparency committee
venous thrombosis
venous thrombosis
pyridines
thiazoles
pyridines
thiazoles

---
https://www.has-sante.fr/portail/jcms/c_2847889/fr/colchimax
2018
false
France
French
Acute idiopathic pericarditis (disorder)
treatment outcome
pericarditis
drug therapy, combination
anti-inflammatory agents
morpholines
drug combinations
opium
colchicine
tiemonium methylsulfate
administration, oral
insurance, health, reimbursement
evaluation of the transparency committee

---
https://www.has-sante.fr/portail/jcms/c_2847892/fr/colchicine-opocalcium
2018
false
France
French
Acute idiopathic pericarditis (disorder)
treatment outcome
pericarditis
drug therapy, combination
anti-inflammatory agents
colchicine
administration, oral
insurance, health, reimbursement
evaluation of the transparency committee

---
Inscription d'une solution buvable adaptée à l’extension d’indication chez les jeunes enfants et nourrissons âgés de 14 jours à 2 ans.
https://www.has-sante.fr/portail/jcms/c_2831910/fr/kaletra
2018
false
France
French
lopinavir-ritonavir drug combination
lopinavir-ritonavir drug combination
infant, newborn
infant
child, preschool
lopinavir and ritonavir
hiv infections
anti-hiv agents
insurance, health, reimbursement
treatment outcome
HIV-1
drug therapy, combination
anti-hiv agents
administration, oral
evaluation of the transparency committee
ritonavir
lopinavir
drug combinations
ritonavir
lopinavir
drug combinations

---
Extension d'indication
https://www.has-sante.fr/portail/jcms/c_2831672/fr/lucentis
2018
false
France
French
evaluation of the transparency committee
ranibizumab
insurance, health, reimbursement
treatment outcome
choroidal neovascularization
intravitreal injections
visual acuity
adult
visual acuity reduced
Ranibizumab
Ranibizumab

---
https://www.has-sante.fr/portail/jcms/c_2847936/fr/flucortac
2018
false
true
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
insurance, health, reimbursement
fludrocortisone
fludrocortisone acetate
orthostatic intolerance
orthostatic neurogenic hypotension
fludrocortisone
fludrocortisone

---
https://www.has-sante.fr/portail/jcms/c_2820671/fr/imeth
2018
false
France
French
Prefilled Syringe Dosage Form
injections, subcutaneous
injections, intramuscular
crohn disease
methotrexate
adult
insurance, health, reimbursement
methotrexate
evaluation of the transparency committee

---
https://www.has-sante.fr/portail/jcms/c_2839029/fr/signifor
2018
false
false
France
French
evaluation of the transparency committee
acromegaly
pituitary acth hypersecretion
pasireotide
pasireotide
orphan drug production
pasireotide
adult
somatostatin
injections, intramuscular
aged
insurance, health, reimbursement
treatment outcome
risk management
product surveillance, postmarketing

---
http://www.cfp.ca/content/64/2/e64
2018
false
false
true
Canada
French
practice guideline
medical marijuana
algorithms
chronic pain
nausea
vomiting
muscle spasticity
neuralgia
medical marijuana
cannabinoids

---
https://www.has-sante.fr/portail/jcms/c_2827579/fr/eprex
2018
false
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
treatment outcome
insurance, health, reimbursement
adult
erythropoietin
myelodysplastic syndromes
anemia
hematinics
Eprex
Epoetin Alfa

---
https://www.has-sante.fr/portail/jcms/c_2827576/fr/orencia
2018
false
false
false
false
France
French
evaluation of the transparency committee
Abatacept
arthritis, rheumatoid
insurance, health, reimbursement
abatacept

---
https://www.has-sante.fr/portail/jcms/c_2827570/fr/opticron-unidose
2018
false
false
false
false
France
French
evaluation of the transparency committee
ophthalmic solutions
administration, ophthalmic
cromolyn sodium
cromoglicic acid
anti-allergic agents
Single Dose Vial

---
https://www.has-sante.fr/portail/jcms/c_2827567/fr/crinesal
2018
false
false
false
false
France
French
evaluation of the transparency committee
carbetocin
carbetocin
Prefilled Syringe Dosage Form
Injectable Solution Dosage Form
uterine inertia
oxytocics
treatment outcome
cesarean section
Anesthesia for cesarean section (procedure)
anesthesia, epidural
uterine inertia
anesthesia, spinal
injections, intravenous
oxytocin
oxytocin

---
https://www.has-sante.fr/portail/jcms/c_2827564/fr/acide-folique-ccd
2018
false
false
false
false
France
French
evaluation of the transparency committee
-
folic acid
folic acid
folic acid
folic acid

---
https://www.has-sante.fr/portail/jcms/c_2827561/fr/tramadol-arrow
2018
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
tramadol
tramadol

---
https://www.has-sante.fr/portail/jcms/c_2826594/fr/taxotere
2018
false
false
false
false
France
French
evaluation of the transparency committee
docetaxel
TAC protocol
taxoids
antineoplastic combined chemotherapy protocols
cyclophosphamide
doxorubicin

---
https://www.has-sante.fr/portail/jcms/c_2826591/fr/trh-ferring
2018
false
false
false
false
France
French
evaluation of the transparency committee
thyrotropin-releasing hormone

---
https://www.has-sante.fr/portail/jcms/c_2826579/fr/rocephine
2018
false
false
false
false
France
French
evaluation of the transparency committee
ceftriaxone

---
https://www.has-sante.fr/portail/jcms/c_2825873/fr/dynexan
2018
false
false
false
false
France
French
evaluation of the transparency committee
lidocaine
insurance, health, reimbursement
treatment outcome
lidocaine
administration, buccal

---
https://www.has-sante.fr/portail/jcms/c_2825852/fr/refixia
2018
false
false
false
false
France
French
evaluation of the transparency committee
nonacog beta pegol
coagulation factor IX
hemorrhage
hemorrhage
treatment outcome
hemophilia B
injections, intravenous
factor IX
polyethylene glycols
recombinant proteins

---
Extension d'indication
https://www.has-sante.fr/portail/jcms/c_2825855/fr/stivarga-chc
2018
false
France
French
regorafenib
regorafenib
regorafenib
administration, oral
treatment outcome
insurance, health, reimbursement
adult
antineoplastic agents
antineoplastic agents
evaluation of the transparency committee
carcinoma, hepatocellular
phenylurea compounds
pyridines
phenylurea compounds
pyridines

---
https://www.has-sante.fr/portail/jcms/c_2829040/fr/atrovent-nasal
2018
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
ipratropium bromide
ipratropium bromide
ipratropium

---
https://www.has-sante.fr/portail/jcms/c_2829031/fr/ceris
2018
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
trospium chloride
trospium
benzilates
nortropanes

---
https://www.has-sante.fr/portail/jcms/c_2827588/fr/softacort
2018
false
false
false
France
French
evaluation of the transparency committee
administration, ophthalmic
treatment outcome
insurance, health, reimbursement
hydrocortisone sodium phosphate
hydrocortisone sodium phosphate
hydrocortisone
anti-inflammatory agents
anti-inflammatory agents
ophthalmic solutions
hydrocortisone
conjunctivitis
conjunctivitis, allergic
Noninfective conjunctivitis

---
https://www.has-sante.fr/portail/jcms/c_2829034/fr/opdivo
2018
false
false
false
France
French
treatment outcome
evaluation of the transparency committee
nivolumab
infusions, intravenous
nivolumab
antineoplastic agents
antineoplastic agents
adult
carcinoma, squamous cell
upper aerodigestive tract neoplasms
disease progression
Cancer Progression
quality of life
survival analysis
head and neck neoplasms
antibodies, monoclonal

---
https://www.has-sante.fr/portail/jcms/c_2829043/fr/besponsa
https://www.has-sante.fr/portail/jcms/c_2829043/fr/besponsa-inotuzumab-ozogamicine-anticorps-monoclonal-antineoplasique
2018
false
false
false
France
French
orphan drug production
treatment outcome
inotuzumab ozogamicin
inotuzumab ozogamicin
Adult B Acute Lymphoblastic Leukemia
antineoplastic agents
antineoplastic agents
precursor b-cell lymphoblastic leukemia-lymphoma
adult
sialic acid binding ig-like lectin 2
precursor b-cell lymphoblastic leukemia-lymphoma
precursor b-cell lymphoblastic leukemia-lymphoma
sialic acid binding ig-like lectin 2
CD22 protein, human
CD22 protein, human
infusions, intravenous
antibodies, monoclonal, humanized
evaluation of the transparency committee
recurrence
guidelines for drug use
survival analysis
Philadelphia chromosome negative
Philadelphia chromosome positive
inotuzumab ozogamicin
antibodies, monoclonal, humanized

---
http://conseil-scientifique.public.lu/fr/publications/oncologie/cannabis-mise-a-jour-2018.html
2018
false
false
true
Luxembourg
French
practice guideline
luxembourg
Cancer Pain
cannabinoids
cannabis
marijuana smoking
medical marijuana
treatment outcome
chemotherapy-induced nausea and vomiting
anorexia
weight loss
legislation, drug
neoplasms
antineoplastic agents
Drug-Related side effects and adverse reactions
nausea
vomiting

---
https://www.has-sante.fr/portail/jcms/c_2829388/fr/dipentum
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
olsalazine
olsalazine sodium
olsalazine
aminosalicylic acids

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=43087
2018
false
false
false
France
French
drug recalls
abortion on demand
Off-Label use
misoprostol
labor, induced
abortion, therapeutic
abortion, spontaneous
abortion early
fetal death
legislation
patient care management
misoprostol
gemeprost
misoprostol
gemeprost
legislation, drug
insurance, health, reimbursement
drug prescriptions
abortion, legal
alprostadil
alprostadil

---
http://ansm.sante.fr/S-informer/Actualite/Information-relative-a-l-offre-therapeutique-en-gynecologie-suite-a-l-arret-de-commercialisation-de-Cytotec-misoprostol-Point-d-information
2018
false
false
false
France
French
guidelines for drug use
abortion, therapeutic
fetal death
abortion, spontaneous
drug recalls
misoprostol
misoprostol
abortifacient agents, nonsteroidal
oxytocics
administration, oral

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Ruptures-de-stock-des-medicaments/TENORDATE-gelule-Arret-de-commercialisation
2018
false
false
false
France
French
drug information
drug recalls
administration, oral
drug combinations
atenolol
nifedipine
Atenolol+nifedipine (product)
antihypertensive agents
atenolol and nifedipine

---
https://www.has-sante.fr/portail/jcms/c_2830026/fr/colofoam
2018
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
hydrocortisone
hydrocortisone acetate
hydrocortisone
hydrocortisone

---
https://www.has-sante.fr/portail/jcms/c_2830023/fr/betesil
2018
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
betamethasone
betamethasone valerate

---
https://www.has-sante.fr/portail/jcms/c_2830619/fr/theostat-lp
2018
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
theophylline
theophylline

---
https://www.has-sante.fr/portail/jcms/c_2830391/fr/smecta
2018
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
diosmectite
diosmectite
smecta
silicates
Smectite
silicates

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=60210811
2018
false
false
false
France
French
summary of product characteristics
package leaflet
levothyroxine sodium
capsules
thyroxine
levothyroxine sodium
Levothyroxine Sodium
thyroxine

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=61296560
2018
false
false
false
France
French
summary of product characteristics
package leaflet
levothyroxine sodium
capsules
thyroxine

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=60441558
2018
false
false
false
France
French
summary of product characteristics
package leaflet
levothyroxine sodium
capsules
thyroxine

---
https://www.has-sante.fr/portail/jcms/c_2831919/fr/divarius
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
paroxetine
paroxetine
Paroxetine Mesylate

---
https://www.has-sante.fr/portail/jcms/c_2831913/fr/gutron
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
midodrine
midodrine hydrochloride
midodrine

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004174/human_med_002211.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
semaglutide
semaglutide
drug approval
europe
treatment outcome
adult
diabetes mellitus, type 2
injections, subcutaneous
Pre-filled Pen Syringe
Glucagon-Like Peptide-1 Receptor
hemoglobin A, glycosylated
cardiovascular diseases
diabetes complications
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
semaglutide
glucagon-like peptides
glucagon-like peptides

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004195/human_med_002204.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
hemophilia A
hemorrhage
hemorrhage
adult
adolescent
aged
injections, intravenous
factor VIII
recombinant proteins
recombinant proteins
coagulation factor VIII
product surveillance, postmarketing
continuity of patient care
drug evaluation, preclinical

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004138/human_med_002210.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
dehydroepiandrosterone
product surveillance, postmarketing
postmenopause
Vulvovaginal atrophy
atrophy
vulva
vagina
vaginal suppositories
administration, intravaginal
sex hormones and modulators of the genital system
adult
aged
continuity of patient care
dehydroepiandrosterone
suppositories

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004275/human_med_002224.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
burosumab
orphan drug production
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
familial hypophosphatemic rickets
infant
child
adolescent
injections, subcutaneous
fibroblast growth factor 23
product surveillance, postmarketing
continuity of patient care
familial hypophosphatemic rickets
drug interactions
drug evaluation, preclinical
fibroblast growth factors

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004433/human_med_002207.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
benralizumab
benralizumab
drug approval
europe
treatment outcome
asthma
Eosinophilic asthma
pulmonary eosinophilia
Prefilled Syringe Dosage Form
injections, subcutaneous
interleukin-5 receptor alpha subunit
product surveillance, postmarketing
pregnancy
breast feeding
drug evaluation, preclinical
benralizumab
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004416/human_med_002221.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
hydrocortisone
drug approval
europe
treatment outcome
hydrocortisone
infant
adolescent
child
infant, newborn
administration, oral
hydrocortisone
hormone replacement therapy
adrenal insufficiency
drug interactions
pregnancy
breast feeding
hydrocortisone

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004406/human_med_002236.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
emicizumab
drug approval
europe
treatment outcome
emicizumab
hemophilia A
hemorrhage
hemorrhage
Factor VIII antibody (substance)
injections, subcutaneous
product surveillance, postmarketing
adult
child
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
emicizumab
antibodies, bispecific
antibodies, monoclonal, humanized
antibodies, bispecific
antibodies, monoclonal, humanized

---
https://www.has-sante.fr/portail/jcms/c_2826600/fr/spinraza
https://www.has-sante.fr/portail/jcms/c_2826600/fr/spinraza-nusinersen-oligonucleotide-antisens
2018
false
false
false
France
French
treatment outcome
orphan drug production
oligonucleotides
spinal muscular atrophies of childhood
injections, spinal
survival of motor neuron 1 protein
survival of motor neuron 2 protein
genetic diseases, inborn
spinal muscular atrophies of childhood
child
infant
chromosomes, human, pair 5
nusinersen
evaluation of the transparency committee
ISIS 396443
guidelines for drug use

---
https://www.has-sante.fr/portail/jcms/c_2826597/fr/elmiron
https://www.has-sante.fr/portail/jcms/c_2826597/fr/elmiron-pentosan-sodique-polysulfate-ou-pps
2018
false
false
false
France
French
treatment outcome
pentosan polysulfate sodium
administration, oral
Painful Bladder Syndrome
adult
evaluation of the transparency committee
Hunner's ulcer (disorder)
Glomerulations
urinary incontinence, urge
guidelines for drug use
Pentosan Polysulphate Sodium
pentosan sulfuric polyester
cystitis, interstitial

---
https://www.has-sante.fr/portail/jcms/c_2831898/fr/xybilun
2018
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
treatment outcome
Sildenafil Citrate
administration, oral
erectile dysfunction
Buccal Film Dosage Form
urological agents
sildenafil
insurance, health, reimbursement
phosphodiesterase 5 inhibitors

---
https://www.has-sante.fr/portail/jcms/c_2831889/fr/euphylline-l-a
2018
false
false
false
false
France
French
evaluation of the transparency committee
theophylline
treatment outcome
insurance, health, reimbursement
theophylline

---
https://www.has-sante.fr/portail/jcms/c_2831886/fr/vitamine-d3-bon
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
colecalciferol
cholecalciferol

---
https://www.has-sante.fr/portail/jcms/c_2831684/fr/propylex
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
propylthiouracil
propylthiouracil

---
https://www.has-sante.fr/portail/jcms/c_2831681/fr/daonil-hemi-daonil
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
glibenclamide
glyburide

---
https://www.has-sante.fr/portail/jcms/c_2831675/fr/imodium-enfants
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
loperamide
Loperamide Hydrochloride
child
imodium
loperamide

---
https://www.has-sante.fr/portail/jcms/c_2830789/fr/ticarpen
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
ticarcillin
ticarcillin

---
https://www.has-sante.fr/portail/jcms/c_2830780/fr/stagid
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
metformin
metformin

---
https://www.medinfo-verlag.ch/files/download/1cd9f615c9c49a3
2018
false
false
false
Switzerland
French
journal article
atrial fibrillation
anticoagulants
aged
stroke

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004585/human_med_002229.jsp&mid=WC0b01ac058001d124
2018
false
United Kingdom
French
English
syndication feed
drugs, generic
anagrelide
drug approval
europe
drug interactions
pregnancy
breast feeding
Anagrelide hydrochloride 500micrograms capsule (product)
Anagrelide hydrochloride 1mg capsule (product)
thrombocythemia, essential
treatment outcome
anagrelide
quinazolines
anagrelide
administration, oral
quinazolines
drug evaluation
summary of product characteristics
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004274/human_med_002233.jsp&mid=WC0b01ac058001d124
2018
false
United Kingdom
English
French
syndication feed
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
efavirenz
drugs, generic
Oral form efavirenz + emtricitabine + tenofovir (product)
europe
anti-hiv agents
acquired immunodeficiency syndrome
reverse transcriptase inhibitors
anti-hiv agents
drug combinations
hiv infections
administration, oral
treatment outcome
drug evaluation
reverse transcriptase inhibitors
HIV-1
adult
drug approval
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
emtricitabine, tenofovir disoproxil and efavirenz
package leaflet
drug evaluation
summary of product characteristics
benzoxazines

---
http://www.afef.asso.fr/ckfinder/userfiles/files/recommandations-textes-officiels/recommandations/VF%20INTERACTIF-%20RECO-VHC%20AFEF.pdf
2018
false
false
true
France
French
practice guideline
hepatitis C
hepatitis C
hepatitis C
watchful waiting
france
disease eradication
mass screening
continuity of patient care
antiviral agents
viral load
Hepatitis C Viral Load Measurement
coinfection
sofosbuvir-velpatasvir drug combination
Genotype determination (procedure)
hepatitis C
genotype
drug resistance, viral
Decompensated cirrhosis
liver cirrhosis
Hepatitis C virus NS3/4A protease inhibitor (substance)
protease inhibitors
Hepatitis C virus protein NS5A inhibitor (substance)
liver transplantation
algorithms
Sofosbuvir
carbamates
drug combinations
Heterocyclic Compounds, 4 or More Rings

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Conduite-a-tenir-en-cas-de-rupture-d-approvisionnement-de-Polaramine-injectable-Point-d-information
2018
false
false
false
false
France
French
pharmacovigilance note
injections
dexchlorpheniramine maleate
dexchlorpheniramine
histamine h1 antagonists
urticaria
adult
acute disease
Acute urticaria (disorder)
promethazine
promethazine
anti-allergic agents
histamine h1 antagonists
premedication
dexchlorpheniramine
chlorpheniramine

---
http://ansm.sante.fr/S-informer/Actualite/Propositions-d-utilisation-du-facteur-Willebrand-Wilfactin-R-en-periode-de-tensions-d-approvisionnement-Point-d-information
2018
false
false
false
France
French
von willebrand factor
von willebrand factor
von Willebrand factor
injections, intravenous
chemoprevention
drug combinations
von willebrand factor and coagulation factor VIII in combination
von willebrand factor
factor VIII
risk factors
continuity of patient care
thrombosis
hemorrhage
von willebrand diseases
Long-term drug therapy (procedure)
pharmacovigilance note
guidelines for drug use

---
http://www.inesss.qc.ca/nc/publications/publications/publication/avis-sur-la-reanimation-cardiorespiratoire-rcr-dans-le-contexte-de-ladministration-de-naloxone-po.html
2018
false
false
false
Canada
French
cardiopulmonary resuscitation
Overdose of opiate (disorder)
practice guideline
guidelines for drug use
naloxone
narcotic antagonists
poisoning
injections, intramuscular
administration, intranasal
opioids
morphine derivatives
analgesics, opioid

---
http://www.omedit-normandie.fr/boite-a-outils/antidotes-et-medicaments-d-urgence/antidotes-et-medicaments-d-urgence,2185,2391.html
2018
false
false
false
France
French
emergency treatment
antidotes
poisoning
drug overdose
prescription drug misuse
antidotes
Poisoning due to chemical substance (disorder)
practice guideline
guidelines for drug use
mushroom poisoning
mercury poisoning
snake bites
lead poisoning
acute disease
rodenticides
Pesticide poisoning (disorder)
plant poisoning
Digitalis purpurea poisoning (disorder)
Poisoning by digitalis glycoside (disorder)
botulism
Heparin-induced thrombocytopenia (disorder)
Drug Extravasation
Poisoning by local anesthetic (disorder)
Poisoning by beta-adrenergic blocking drug (disorder)
Accidental poisoning by hydrocyanic acid gas (disorder)
Toxic effect of cyanide (disorder)
Hereditary angioedema attack
angioedemas, hereditary
Dabigatran
Neuroleptic-induced Parkinsonism (disorder)
Hyperammonemic encephalopathy (disorder)
mitochondrial cytopathy
dipropylacetamide
valproate sodium
Poisoning by sodium valproate (disorder)
valproic acid
Kearns-Sayre syndrome
mitochondrial myopathies
valproic acid

---
http://toxinfo.ch/customer/files/35/Antidotliste_2018_F.pdf
2018
false
false
false
false
Switzerland
French
guidelines for drug use
antidotes
antidotes
poisoning

---
https://www.has-sante.fr/portail/jcms/c_2839032/fr/noyada
2018
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
treatment outcome
guidelines for drug use
captopril
captopril
captopril
angiotensin-converting enzyme inhibitors
angiotensin-converting enzyme inhibitors
child
adult
deglutition disorders
hypertension
heart failure
myocardial infarction
diabetic nephropathies
pharmaceutical solutions
insurance, health, reimbursement

---
https://www.has-sante.fr/portail/jcms/c_2839014/fr/glucor
2018
false
false
false
false
France
French
evaluation of the transparency committee
acarbose
insurance, health, reimbursement
hypoglycemic agents
acarbose

---
https://www.has-sante.fr/portail/jcms/c_2820103/fr/oxervate-cenegermine-forme-recombinante-du-facteur-de-croissance-des-cellules-nerveuses-humain
https://www.has-sante.fr/portail/jcms/c_2820103/fr/oxervate
2018
false
false
false
France
French
treatment outcome
nerve growth factor
Neurotrophic keratopathy
keratitis
adult
ophthalmic solutions
administration, ophthalmic
recombinant proteins
recombinant proteins
cenegermin
evaluation of the transparency committee
guidelines for drug use

---
https://www.has-sante.fr/portail/jcms/c_2820674/fr/polygynax-et-polygynax-virgo-neomycine-polymyxine-b-nystatine
https://www.has-sante.fr/portail/jcms/c_2820674/fr/polygynax-polygynax-virgo
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
nystatin, combinations
Neomycin Sulfate
drug combinations
nystatin
vaginosis, bacterial
guidelines for drug use
polymyxin B sulfate
anti-bacterial agents
antifungal agents
insurance, health, reimbursement
neomycin
polymyxin B

---
https://www.has-sante.fr/portail/jcms/c_2841491/fr/calciprat
2018
false
false
false
false
France
French
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
calcium carbonate
calcium carbonate

---
http://sfar.org/wp-content/uploads/2018/03/2_Gestion-des-agents-antiplaquettaires-pour-une-procedure-invasive-programmee.pdf
https://doi.org/10.1016/j.anrea.2018.01.002
2018
false
false
false
France
French
platelet aggregation inhibitors
hemorrhage
postoperative complications
platelet aggregation inhibitors
embolism and thrombosis
aspirin
administration, oral
clopidogrel
Prasugrel Hydrochloride
ticagrelor
risk management
risk assessment
continuity of patient care
patient safety
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
platelet aggregation inhibitors excl. heparin
surgical procedures, operative
blood loss, surgical
perioperative period
ticlopidine
ticlopidine
adenosine
adenosine

---
http://www.snfge.org/content/4-cancer-colorectal-metastatique
2018
false
false
France
French
colonic neoplasms
neoplasm metastasis
colonic neoplasms
signs and symptoms
liver neoplasms
liver neoplasms
hepatectomy
liver neoplasms
neoplasm metastasis
lung neoplasms
palliative care
neoplasm metastasis
clinical trials as topic
continuity of patient care
antineoplastic protocols
colonic neoplasms
antibodies, monoclonal
antibodies, monoclonal
antineoplastic agents
antineoplastic agents
iatrogenic disease
hypertension
skin diseases
hypertension
prognosis
practice guideline
audiovisual aids
bibliography
table

---
https://www.has-sante.fr/portail/jcms/c_2827579/fr/eprex-epoetine-alfa-agent-stimulant-l-erythropoiese
2018
false
false
France
French
Epoetin Alfa
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
adult
myelodysplastic syndromes
anemia
drug approval
Epoetin Alfa
hematinics
erythropoietin
hematinics
guidelines for drug use

---
http://www.cochrane.org/fr/CD000996/le-role-des-corticoides-inhales-dans-la-prise-en-charge-de-la-bronchectasie
2018
false
true
false
false
France
treatment outcome
review of literature
french abstract
steroids
administration, inhalation
bronchiectasis

---
https://www.canada.ca/fr/sante-publique/services/grossesse/acide-folique.html
2018
false
false
Canada
French
pregnancy
folic acid
neural tube defects
patients guideline

---
http://lecrat.fr/spip.php?page=article&id_article=735
2018
false
France
French
antifibrinolytic agents
tranexamic acid
breast feeding
pregnancy
tranexamic acid
drug information

---
http://www.cochrane.org/fr/CD008509/les-alpha-bloquants-comme-traitement-medical-expulsif-des-calculs-ureteraux
2018
false
false
false
false
France
French
review of literature
french abstract
treatment outcome
adrenergic alpha-antagonists
ureteral calculi
adrenergic alpha-antagonists

---
https://www.has-sante.fr/portail/jcms/c_1252051/fr/prevention-vasculaire-apres-un-infarctus-cerebral-ou-un-accident-ischemique-transitoire
2018
false
true
true
false
France
French
practice guideline
cerebral infarction
ischemic attack, transient
stroke
myocardial infarction
adult
hypertension
antihypertensive agents
dyslipidemias
hydroxymethylglutaryl-coa reductase inhibitors
diabetes mellitus
smoking
alcohol drinking
obesity
hyperhomocysteinemia
atrial fibrillation
vitamin K
anticoagulants
foramen ovale, patent
fibrinolytic agents
heart valve prosthesis
heart valve diseases
platelet aggregation inhibitors
carotid stenosis
endarterectomy, carotid
vertebral artery dissection
anticoagulotherapy

---
http://sfar.org/wp-content/uploads/2018/07/Antibioprophylaxie-RFE-mise-a-jour-2018.pdf
2018
true
false
true
false
France
French
consensus
antibiotic prophylaxis
anti-bacterial agents
surgical procedures, operative
adult

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Spray-nasal-de-naloxone-Nalscue-entree-en-vigueur-de-l-AMM-le-8-janvier-2018
2018
false
false
false
France
French
drug information
drug approval
france
naloxone
administration, intranasal
nasal sprays
narcotic antagonists
emergency treatment
Naloxone Hydrochloride
naloxone
poisoning
opiate alkaloids
drug users
Overdose of opiate (disorder)
patient education as topic

---
http://www.inesss.qc.ca/nc/publications/publications/publication/usage-optimal-des-antipsychotiques-et-la-prise-en-charge-non-pharmacologique-des-symptomes-comportem.html
2018
false
false
false
Canada
French
antipsychotic agents
Off-Label use
practice guideline
Dementia with behavioral disturbance (disorder)
aged
Neurocognitive Disorders
Neurocognitive Disorders
residential facilities
quebec
Deprescriptions
inappropriate prescribing
guidelines for drug use
antipsychotics
dementia

---
https://www.has-sante.fr/portail/jcms/c_2819909/fr/asmanex-twisthaler
2018
false
false
false
false
France
French
evaluation of the transparency committee
Asmanex Twisthaler
mometasone
Mometasone Furoate

---
https://www.has-sante.fr/portail/jcms/c_2819906/fr/zymad
2018
false
false
false
false
France
French
evaluation of the transparency committee
cholecalciferol

---
https://www.has-sante.fr/portail/jcms/c_2819903/fr/soriatane
2018
false
false
false
false
France
French
evaluation of the transparency committee
acitretin
acitretin

---
https://www.has-sante.fr/portail/jcms/c_2820680/fr/tergynan
https://www.has-sante.fr/portail/jcms/c_2820680/fr/tergynan-neomycine-metronidazole-nystatine
2018
false
true
false
false
France
French
evaluation of the transparency committee
treatment outcome
nystatin, combinations
metronidazole
Neomycin Sulfate
drug combinations
nystatin
vaginosis, bacterial
guidelines for drug use
anti-bacterial agents
antifungal agents
insurance, health, reimbursement
neomycin

---
https://www.has-sante.fr/portail/jcms/c_2820112/fr/bevitine
2018
false
false
false
false
France
French
evaluation of the transparency committee
thiamine

---
https://www.has-sante.fr/portail/jcms/c_2820106/fr/humalog
2018
false
false
false
false
France
French
evaluation of the transparency committee
injections, subcutaneous
Pre-filled Pen Syringe
hypoglycemic agents
insurance, health, reimbursement
treatment outcome
adult
child
diabetes mellitus
insulin lispro
insulin lispro

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Trasylol-aprotinine-Remise-a-disposition-sur-le-marche-avec-restriction-d-indication-et-nouvelle-information-de-securite-Lettre-aux-professionnels-de-sante
2018
false
false
false
France
French
aprotinin
aprotinin
aprotinin
guidelines for drug use
patient safety
aprotinin
risk assessment
hemostatics
hemostatics
hemostatics
extracorporeal circulation
coronary artery bypass
blood loss, surgical
heparin
drug therapy, combination
continuity of patient care
anticoagulants
blood coagulation tests
Heparin therapy (procedure)
thromboembolism
product surveillance, postmarketing

---
http://www.cfp.ca/content/64/1/e1
2018
false
false
false
Canada
French
Deprescriptions
antipsychotic agents
journal article
practice guideline
Evidence-Based medicine
review of literature
aged
inappropriate prescribing
housing for the elderly
homes for the aged
algorithms
sleep initiation and maintenance disorders
withholding treatment
canada
continuity of patient care
sleep initiation and maintenance disorders
polypharmacy
antipsychotic agents
antipsychotics
Long-Term care

---
https://www.rmlg.ulg.ac.be/aboel.php?num_id=2974&langue=FR
2018
false
false
false
Belgium
French
journal article
diabetes mellitus, type 2
cardiovascular diseases
hypoglycemic agents
empagliflozin
treatment outcome
empagliflozin
Sodium-Glucose transporter 2
comparative effectiveness research
Liraglutide
liraglutide
Glucagon-Like Peptide-1 Receptor
incretins
case reports
prognosis
cardiovascular diseases
drug therapy, combination
diabetes mellitus, type 2
renal insufficiency, chronic
belgium
insurance, health, reimbursement
Clinical Decision-Making
risk factors
benzhydryl compounds
glucosides

---
http://www.prescrire.org/Fr/3/31/53765/0/NewsDetails.aspx
2018
false
false
false
France
French
journal article
pharmaceutical preparations
risk adjustment
risk
Drug-Related side effects and adverse reactions
risks and benefits
pharmaceutical preparations
risk assessment

---
https://www.has-sante.fr/portail/jcms/c_2821753/fr/primperan
2018
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
metoclopramide

---
https://www.has-sante.fr/portail/jcms/c_2823238/fr/adoport
2018
false
true
false
false
France
French
evaluation of the transparency committee
tacrolimus
tacrolimus
treatment outcome

---
https://www.has-sante.fr/portail/jcms/c_2823235/fr/feiba
2018
false
false
false
false
France
French
evaluation of the transparency committee
factor VIII inhibitor bypassing activity
Feiba
blood coagulation factors
blood coagulation factors

---
https://www.has-sante.fr/portail/jcms/c_2823583/fr/gastropulgite
2018
false
true
false
false
France
French
evaluation of the transparency committee
attapulgite, combinations
treatment outcome
attapulgite
drug combinations
magnesium compounds
silicon compounds

---
http://www.omedit-centre.fr/portail/gallery_files/site/136/2953/5062/7873.pdf
2018
false
false
false
France
French
chronic pain
analgesics, opioid
adult
guidelines for drug use
drug overdose
risk factors
Current Opioid Misuse Measure Questionnaire
treatment outcome
pain measurement

---
https://www.has-sante.fr/portail/jcms/c_2823761/fr/perindopril/indapamide-arrow-lab
2018
false
false
false
false
France
French
evaluation of the transparency committee
indapamide, perindopril drug combination
indapamide
perindopril
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2825238/fr/travatan
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
travoprost
Travoprost

---
https://www.has-sante.fr/portail/jcms/c_2825235/fr/nutrivisc
2018
false
false
false
false
France
French
evaluation of the transparency committee
artificial tears and other indifferent preparations
povidone
administration, ophthalmic
insurance, health, reimbursement
treatment outcome

---
https://www.has-sante.fr/portail/jcms/c_2824813/fr/ozidia
2018
false
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
glipizide
glipizide

---
https://www.has-sante.fr/portail/jcms/c_2824795/fr/nicoretteskin
2018
false
false
false
false
France
French
evaluation of the transparency committee
administration, cutaneous
transdermal patch
nicotine
tobacco use cessation products
nicotine
tobacco use disorder

---
https://www.has-sante.fr/portail/jcms/c_2824488/fr/clarityne
2018
false
false
false
false
France
French
evaluation of the transparency committee
loratadine
administration, oral
treatment outcome
histamine H1 antagonists, non-sedating
claritin
loratadine

---
http://www.gftc-calculateur.fr/khorana.html
2018
false
false
false
France
French
antineoplastic agents
venous thromboembolism
venous thromboembolism
risk assessment
clinical tool

---
http://www.thromboclic.fr/medecin/recommandations/recommandations_sur_dabigatran.html
2018
false
false
false
France
French
guidelines for drug use
Dabigatran
hemorrhage
Dabigatran
administration, oral
risk adjustment
antithrombins

---
http://www.thromboclic.fr/medecin/recommandations/recommandations_sur_rivaroxaban.html
2018
false
false
false
France
French
guidelines for drug use
hemorrhage
administration, oral
Rivaroxaban
Rivaroxaban
risk adjustment
Factor Xa Inhibitors

---
http://www.thromboclic.fr/medecin/recommandations/recommandations_sur_apixaban.html
2018
false
false
false
France
French
guidelines for drug use
hemorrhage
risk adjustment
administration, oral
apixaban
Factor Xa Inhibitors
pyrazoles
pyridones

---
Jorveza budesonide
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004655/human_med_002212.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
budesonide
drug approval
europe
orphan drug production
treatment outcome
drug interactions
pregnancy
breast feeding
budesonide
eosinophilic esophagitis
administration, oral
Oral form budesonide (product)
Orally Disintegrating Tablet Dosage Form
adult
anti-inflammatory agents
anti-inflammatory agents
glucocorticoids
glucocorticoids
drug evaluation, preclinical
budesonide

---
VeraSeal - human fibrinogen / human thrombin
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004446/human_med_002197.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
Fibrinogen+thrombin (product)
drug approval
europe
treatment outcome
local hemostatics combinations
hemostatics
hemostatics
blood loss, surgical
administration, topical
product surveillance, postmarketing
pharmaceutical solutions
tissue adhesives
hemostasis, surgical
adult
aged
Repair of blood vessel with suture (procedure)
vascular surgical procedures
fibrinogen
thrombin

---
Prevymis letermovir
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004536/human_med_002200.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
letermovir
drug approval
europe
treatment outcome
orphan drug production
hematopoietic stem cell transplantation
allografts
Allogeneic Hematopoietic Stem Cell Transplantation
antiviral agents
antiviral agents
cytomegalovirus infections
Cytomegalovirus infection reactivation
administration, oral
infusions, intravenous
terminase
enzyme inhibitors
enzyme inhibitors
pregnancy
breast feeding
drug interactions
antivirals for systemic use
product surveillance, postmarketing
adult
aged
drug evaluation, preclinical
letermovir
AIC246
acetates
quinazolines
AIC246
endodeoxyribonucleases
acetates
quinazolines

---
Trelegy Ellipta fluticasone furoate / umeclidinium / vilanterol
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004363/human_med_002191.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
vilanterol, umeclidinium bromide and fluticasone furoate
drug approval
europe
treatment outcome
vilanterol
fluticasone furoate
drug combinations
umeclidinium
glucocorticoids
glucocorticoids
muscarinic antagonists
muscarinic antagonists
pulmonary disease, chronic obstructive
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
administration, inhalation
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Fluticasone
vilanterol
umeclidinium
fluticasone furoate
GSK573719
benzyl alcohols
chlorobenzenes
androstadienes
quinuclidines
GSK573719
quinuclidines
benzyl alcohols
chlorobenzenes
androstadienes

---
Ocrevus ocrelizumab
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004043/human_med_002187.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
ocrelizumab
ocrelizumab
treatment outcome
drug approval
europe
multiple sclerosis, relapsing-remitting
multiple sclerosis, primary progressive
adult
infusions, intravenous
antigens, CD20
antibodies, monoclonal, humanized
immunologic factors
immunologic factors
product surveillance, postmarketing
premedication
continuity of patient care
drug monitoring
methylprednisolone
glucocorticoids
histamine antagonists
Infusion-Related Reaction
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
ocrelizumab
antibodies, monoclonal, humanized
multiple sclerosis, chronic progressive

---
Elebrato Ellipta - fluticasone furoate / umeclidinium / vilanterol
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004781/human_med_002182.jsp&mid=WC0b01ac058001d124
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
vilanterol, umeclidinium bromide and fluticasone furoate
drug approval
europe
treatment outcome
vilanterol
fluticasone furoate
drug combinations
umeclidinium
glucocorticoids
glucocorticoids
muscarinic antagonists
muscarinic antagonists
pulmonary disease, chronic obstructive
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
bronchodilator agents
bronchodilator agents
administration, inhalation
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Fluticasone
vilanterol
umeclidinium
fluticasone furoate
GSK573719
benzyl alcohols
chlorobenzenes
androstadienes
quinuclidines
GSK573719
quinuclidines
benzyl alcohols
chlorobenzenes
androstadienes

---
Mvasi - Bevacizumab
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004728/human_med_002217.jsp&mid=WC0b01ac058001d124
2018
false
United Kingdom
English
French
syndication feed
Bevacizumab
Bevacizumab
biosimilar pharmaceuticals
ovarian neoplasms
uterine cervical neoplasms
fallopian tube neoplasms
peritoneal neoplasms
breast feeding
drug interactions
antineoplastic combined chemotherapy protocols
infusions, intravenous
adult
Advanced Malignant Neoplasm
drug evaluation, preclinical
product surveillance, postmarketing
colorectal neoplasms
breast neoplasms
pregnancy
angiogenesis inhibitors
angiogenesis inhibitors
neoplasm metastasis
carcinoma, non-small-cell lung
carcinoma, renal cell
drug approval
treatment outcome
antibodies, monoclonal, humanized
antibodies, monoclonal, humanized
bevacizumab
drug evaluation
summary of product characteristics
package leaflet

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004435/human_med_002202.jsp&mid=WC0b01ac058001d124
2018
false
United Kingdom
English
French
syndication feed
drugs, generic
drug approval
europe
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
tacrolimus
graft rejection
kidney transplantation
liver transplantation
immunosuppressive agents
treatment outcome
Delayed-Action preparations
adult
graft rejection
tacrolimus
immunosuppressive agents
tacrolimus
administration, oral
drug evaluation
package leaflet
summary of product characteristics

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004323/human_med_002188.jsp&mid=WC0b01ac058001d124
2018
false
United Kingdom
French
English
syndication feed
Trastuzumab
Trastuzumab
biosimilar pharmaceuticals
europe
drug interactions
stomach neoplasms
product surveillance, postmarketing
antineoplastic combined chemotherapy protocols
Gastroesophageal Junction Adenocarcinoma
Gastric Adenocarcinoma
HER-2 positive breast cancer
HER-2 positive gastric cancer
Trastuzumab 150mg powder for infusion solution vial (product)
antineoplastic agents
antineoplastic agents
treatment outcome
drug evaluation
infusions, intravenous
drug approval
receptor, erbB-2
neoplasm metastasis
pregnancy
breast feeding
drug storage
drug compounding
breast neoplasms
trastuzumab
antibodies, monoclonal
package leaflet
summary of product characteristics
drug evaluation

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004891/human_med_002206.jsp&mid=WC0b01ac058001d124
2018
false
United Kingdom
English
French
syndication feed
Darunavir
Darunavir
drugs, generic
europe
Darunavir 400mg tablet (product)
Oral form darunavir (product)
hiv protease inhibitors
hiv infections
hiv protease inhibitors
drug evaluation
treatment outcome
drug approval
administration, oral
acquired immunodeficiency syndrome
HIV-1
drug therapy, combination
drug interactions
pregnancy
breast feeding
darunavir
drug evaluation
package leaflet
summary of product characteristics

---
E-mail
21/07/2018


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.